Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases-Reference-Cited by-同舟云学术

Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases

Published:2024-07 Issue:1 Volume:64 Page:107186
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Meschiari Marianna^ORCID,Asquier-Khati Antoine,Tiseo Giusy^ORCID,Luque-Paz David^ORCID,Murri Rita^ORCID,Boutoille David,Falcone Marco,Mussini Cristina,Tattevin Pierre^ORCID

Publisher

Elsevier BV

Reference40 articles.

1. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine);Paul;Clin Microbiol Infect,2022

2. Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections;Tamma;Clin Infect Dis,2022

3. Five-year trends for ventilator-associated pneumonia: correlation between microbiological findings and antimicrobial drug consumption;Fihman;Int J Antimicrob Agents,2015

4. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia;Boselli;Crit Care Med,2003

5. Mechanisms of resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa: results of the GERPA multicenter study;Fournier;Antimicrob Agents Chemother,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms;Current Opinion in Infectious Diseases;2024-07-25